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ABSTRACT
Background Supply and demand- side factors continue to 
undermine voluntary medical male circumcision (VMMC) 
uptake. We assessed relative economic costs of four VMMC 
demand creation/service- delivery modalities as part of a 
randomised controlled trial in Zimbabwe.
Methods Interpersonal communication agents were trained 
and incentivised to generate VMMC demand across five 
districts using four demand creation modalities (standard 
demand creation (SDC), demand creation plus offer of HIV 
self- testing (HIVST), human- centred design (HCD)- informed 
approach, HCD- informed demand creation approach plus 
offer of HIVST). Annual provider financial expenditure analysis 
and activity- based- costing including time- and- motion 
analysis across 15 purposively selected sites accounted 
for financial expenditures and donated inputs from other 
programmes and funders. Sites represented three models of 
VMMC service- delivery: static (fixed) model offering VMMC 
continuously to walk- in clients at district hospitals and 
serving as a district hub for integrated mobile and outreach 
services, (2) integrated (mobile) modelwhere staff move 
from the district static (fixed) site with their commodities 
to supplement existing services or to recently capacitated 
health facilities, intermittently and (3) mobile/outreach model 
offering VMMC through mobile clinic services in more remote 
sites.
Results Total programme cost was $752 585 including 
VMMC service- delivery costs and average cost per client 
reached and cost per circumcision were $58 and $174, 
respectively. Highest costs per client reached were in the HCD 
arm—$68 and lowest costs in standard demand creation 
($52) and HIVST ($55) arms, respectively. Highest cost per 
client circumcised was observed in the arm where HIVST and 
HCD were combined ($226) and the lowest in the HCD alone 
arm ($160). Across the three VMMC service- delivery models, 
unit cost was lowest in static (fixed) model ($54) and highest 
in integrated mobile model ($63). Overall, economies of 
scale were evident with unit costs lower in sites with higher 
numbers of clients reached and circumcised.
Conclusions There was high variability in unit costs across 
arms and sites suggesting opportunities for cost reductions. 
Highest costs were observed in the HCD+HIVST arm when 
combined with an integrated service- delivery setting. 
Mobilisation programmes that intensively target higher 
conversion rates as exhibited in the SDC and HCD arms 
provide greater scope for efficiency by spreading costs.
Trial registration number PACTR201804003064160.
Key questions
What is already known?
 ► Voluntary medical male circumcision (VMMC) is 
effective at reducing risk of female- to- male sexual 
transmission of HIV and is cost- effective.
 ► Supply and demand- side factors continue to under-
mine VMMC uptake, particularly among 20–35 years 
old, the age group at greatest risk of HIV.
 ► Longer- term financial sustainability of VMMC pro-
gramming in an environment characterised by dwin-
dling funding for HIV prevention is a key concern 
partly due to limited data on costs.
What are the new findings?
 ► Demand creation and communication costs consti-
tute the majority of programme costs compared with 
VMMC service- delivery.
 ► Higher VMMC conversion rates provide greater 
scope for efficiency by spreading costs.
What do the new findings imply?
 ► High variability in unit costs across arms and sites 
suggests possible efficiency gains in VMMC service- 
delivery across various platforms.
 ► Intensified demand creation activities are needed to 
optimise uptake of VMMC and achieve optimal utili-
sation of inputs.
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INTRODUCTION
By 2007, three randomised controlled trials (RCTs) among 
over 11 000 men had shown that voluntary medical male 
circumcision (VMMC) was very effective at reducing risk 
of female- to- male sexual transmission of HIV and was cost- 
effective.1–6 In the medium term, circumcising men ages 
20–29 would yield the greatest reduction in HIV incidence, 
and over the long term, would result in the largest impact 
if infants or adolescent boys (≤19 years old) were circum-
cised.7–9 Results of these analyses informed the 11 WHO/
UNAIDS recommendations for VMMC scale- up in 14 high 
HIV prevalence countries in east and southern Africa 
(ESA) to maximise intervention effectiveness at a popu-
lation level.7 These priority countries, Botswana, Eswatini, 
Ethiopia, Kenya, Lesotho, Malawi, Mozambique, Namibia, 
Rwanda, South Africa, Uganda, Tanzania, Zambia and 
Zimbabwe, now number 15 with the addition of South 
Sudan.8
Evidence shows that VMMC has continued to be a 
key contributor to HIV prevention and is cost- effective 
when provided to men most at risk (15–49 years).9–16 
Evidence from modelling work in Zimbabwe shows 
that the modelled cost per HIV infection averted in 
Zimbabwe fell to $811 when only men aged 20–24 years 
were circumcised from $1035 if targeting the broader 
13–29 year age group. In South Africa and elsewhere, 
data suggest that VMMC cost- effectiveness decreases 
steeply with declining effectiveness of VMMC at higher 
ages.17 This has an important impact and implications for 
the speed with which we can address the HIV epidemic 
and the sustainability of VMMC. By December 2019, and 
across the 15 VMMC priority countries combined, nearly 
27 million adolescent and adult men had been circum-
cised and an estimated 340 000 new infections averted, 
including 260 000 infections among men and 75 000 
among women (due to reduced secondary transmission 
from men).7–11 Adult men (20–29 years), however, who 
are at greatest risk of HIV remain hard to reach as the 
majority of VMMC programme clients continue to be 
adolescent boys (≤19 years).18–20
In general, constraints to VMMC uptake across ESA vary 
but include both supply and demand- side factors. On the 
supply- side, VMMC uptake is restricted by shortages of 
both service- delivery sites and VMMC trained healthcare 
workers, a situation compounded by staff attrition.21 22 
Demand- side barriers include poor HIV risk perception 
and healthcare seeking among men; fear of pain associ-
ated with the surgical procedure and local anaesthesia; 
fear of surgical complications; fear of preoperative HIV 
testing, lengthy healing and sexual abstinence period and 
perceived threats to masculinity.23–31 Low demand has also 
been associated with perceived high opportunity costs of 
seeking VMMC services including transport and produc-
tivity losses.20 25 32 33
For Zimbabwe, one of the countries’ worst affected by HIV, 
with a prevalence of 12.9%, modelling studies suggested 
that the greatest reduction in new infections could have 
been achieved if 1.3 million (80% of 13–29- year- old men) 
had been circumcised by 2017.6 20 34 In pursuit of these 
objectives, the VMMC programme had reached only 
842 695 men (all ages) by December 2016; certain ‘groups’ 
such as higher- risk men aged 20–29 remained elusive. 
Higher risk adult men (20–29 years) only constituted 
22% of VMMC clients; 70% of circumcisions were among 
10–19 year- olds. Data suggest that the proportion of clients 
over age 20 years has decreased while the proportion aged 
10–14 and 15–19 years either increased or stabilised over 
time.20 Although circumcision numbers had increased to 
1 157 000 (89%) men (all ages) by December 2017, they 
remained below target (though achieved by 2018) leading 
to revision of the original programme ‘scale- up’ phase—
80% of 15–29- year- old men and 30% of 10–14 year- olds—to 
2021.35 More innovative, robust and cost- effective demand 
creation strategies are clearly required in order to reach 
the desired scale and reach men>20 years and optimise 
the impact of VMMC on HIV incidence.6 13 36 Of concern 
for policymakers, programmers and funders scaling up 
VMMC, there is limited evidence on what works best for 
VMMC demand creation.30 37
A Ugandan programme recruited and empowered 
pregnant women with a package of comprehensive 
VMMC information while aligning the 6 week postcir-
cumcision period and postpartum sexual abstinence.38 
Elsewhere, interventions have increased uptake through 
the offer of either direct fixed financial compensation or 
lottery- based material incentives to men seeking circum-
cision at clinics in Kenya, South Africa and Tanzania, 
or small financial rewards to men referring others in 
Zambia.39–42 A Tanzania trial following a locally tailored 
demand creation strategy including mass media engage-
ment, community mobilisation and targeted service- 
delivery found these more effective and less costly in 
increasing uptake of campaign- delivered VMMC among 
men aged 20–34 years.43
In Zimbabwe, work to address barriers to VMMC 
uptake and better understand how to reach men has 
included market research using private sector meth-
odologies to identify strategies to maximise VMMC 
programme impact by efficiently and effectively 
reaching high- risk men as well as sport- based behaviour 
change programming which included logistical and 
behavioural follow- up.25 44 In this paper, we present 
results of an economic analysis to assess the relative 
efficiency of demand creation models as part of a RCT 
which assessed the effectiveness of a human- centred 
design (HCD)- informed approach combined with HIV 
self- testing (HIVST) in motivating men (15–29 years) to 
take up VMMC.25 HIVST has been shown to increase 
testing coverage among previously unreached popu-
lations, such as men, than conventional HIV testing 
services and might help overcome men’s fear of preop-
erative HIV testing and a positive result, allowing them 
to test in private prior to going to a VMMC health facility 
(even if it meant being tested again).45–47
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METHODS
Setting and study design
The trial design is described in more detail elsewhere.25 In 
short, Population Services International (PSI) Zimbabwe 
redesigned their interpersonal communication (IPC) 
demand creation approaches drawing on market 
research and using HCD- informed methods as discussed 
above. HCD approaches develop solutions to problems 
by involving the human perspective in all steps of the 
problem- solving process.23–25 A 2×2 factorial pragmatic 
RCT compared arms with and without two interventions 
implemented by VMMC mobilisers known as IPC agents: 
(i) standard demand creation (SDC) augmented by 
HCD- informed approach; (ii) standard demand creation 
plus offer of HIVST across five rural districts (Buhera, 
Gokwe North, Mangwe, Mutasa, Zvimba) in 4 of 10 prov-
inces in Zimbabwe, where neither the HCD- informed 
nor HIVST intervention had previously been imple-
mented (table 1).25 IPC agents, the unit of randomisa-
tion, were assigned 1:1:1:1 to four arms, using restricted 
randomisation. Restriction was based on IPC agent char-
acteristics—sex, age and having ≥12 months of VMMC 
mobilisation experience. Each IPC agent was allocated 
to a specific geographic ward (a subunit of a district). 
All mobilised clients received a referral card to link the 
client to the IPC agent at the VMMC site.25 Circumcised 
clients were therefore directly linked to their respective 
arm through the IPC agents who mobilised them. Online 
supplemental file 1 provides additional detailed narrative 
description of the demand creation models and mobili-
sation strategy.
Clients who agreed to be circumcised were offered 
VMMC services through three models (table 2): (1) static 
(fixed) model offering VMMC continuously to walk- in 
clients at district hospitals and serving as a district hub 
for integrated mobile and outreach services, (2) inte-
grated (mobile) model where staff move from the district 
static (fixed) site with their commodities to supplement 
existing services or to recently capacitated health facil-
ities, intermittently and (3) mobile/outreach model 
offering VMMC through mobile clinic services in more 
remote sites.48 In addition to central and local govern-
ment facilities, some of the static (fixed) VMMC sites 
comprised church- run mission hospitals which have 
traditionally served as district hospitals in a public- private 
partnership arrangement with Ministry of Health.
Monthly programme outcome data on the number 
of IPCs trained and active, number of clients reached 
and number of clients circumcised were obtained from 
the trial and used to estimate facility- level average cost 
per client reached or per circumcision.25 From the 143 
IPC agents identified by PSI, 140 were randomly chosen 
for the trial and allocated to one of four study arms. 
Postrandomisation, 20 declined to take part before 
training and were replaced by the implementer. Of 
the 132/140 (94.3%) who attended study arm- specific 
training, 105/132 (79.5%) reported reaching at least 
one client during the trial period and were included in 
the ‘as- treated’ analysis. The mean number of VMMCs/
IPC agent over 6 months between SDC (average 34) and 
the HCD arms (average 35) remained steady although 
there was variability between and within IPC agents. IPCs 
reached a total of 12 929 clients (≥15 years old). Arm 1 
(SDC) reached the highest number of clients (n=4937, 
38%) while arm 4 (HCD +ST) reached the fewest 
(n=2327, 18%). Arms 2 (SDC + HIVST) and 3 (HCD) 
reached 2603 (20%) and 3062 (24%), respectively. 
Thirty- three per cent (4324 clients aged ≥13 years old) 
were circumcised. Arm 1 (SDC) resulted in the highest 
number of clients circumcised (n=1576, 36%) while arm 
4 (HCD+ST) had the fewest circumcisions (n=636, 15%). 
Arms 2 (SDC + HIVST) and 3 (HCD) had 816 (19%) and 
1296 (30%) circumcision procedures, respectively.
Costing overview
The primary costing objective was to measure the costs 
and assess the relative efficiency of implementing the 
four VMMC demand creation approaches. Full economic 
costs were estimated from the provider perspective 
following international costing guidelines for imple-
mentation between May and October 2018.49–51 Costs of 
VMMC demand creation/service- delivery were analysed 
based on actual programme financial expenditures (top- 
down) including all start‐up and initial training costs, 
incurred prior to launch of demand creation and facility- 
level data collection (bottom- up) at public health facil-
ities to ensure the full value of all other resources used 
for VMMC service provision including clinic space and 
equipment; salaries and supplies were captured.52–55 For 
this exercise, 15 facilities (n=5 per service- delivery model) 
offering VMMC services were purposively selected from 
the 5 RCT districts in order to estimate representative 
service- delivery costs retrospectively (12- month period). 
This exercise also accounted for any resources donated 
from other programmes and funders. Start‐up, initial 
training and all other capital costs were annualised using 
the standard 3% discount rate (online supplemental 
table A2).50–52
Valuation of resources including those donated from 
other funders and programmes was done using National 
Pharmaceutical Company of Zimbabwe prices.56–58 Data 
collection was conducted using a standardised set of 
study instruments adapted to the Zimbabwe VMMC 
setting from the PANCEA and ORPHEA projects.53 The 
instruments included a facility questionnaire collecting 
information on several facility characteristics—type of 
facility, urbanicity, ownership (church vs public- sector 
run clinics) and annual number of clients served. The 
questionnaire was administered to facility in- charges 
or their nominees (other management staff or service 
providers).
Time and motion analysis, the gold standard for 
measuring staff allocation of time through direct obser-
vation, allowed us to get better estimates of staff time 
allocation devoted to VMMC services offered as part 
of integrated services at each of the 15 facilities.59 60 
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Participants, specifically drawn from a facility staff roster 
or list (all or every second participant if more than six), 
were asked for permission to be followed up all day over 
a maximum 3- day period in the course of VMMC service 
provision following voluntary informed consent. Time 
and motion observations were also used to capture client 
flow at peak and off- peak periods.
Cost data analysis
In order to estimate the full costs of all resources 
consumed in the demand creation programme and 
VMMC service- delivery, data from the PSI expenditure 
analysis were combined with that from the health facility 
data collection and analysed in a specifically designed 
Microsoft Excel spreadsheet.
Actual financial expenditures were analysed (line by 
line), categorised by input type and allocated to the respec-
tive VMMC demand creation model.51 52 This top- down 
costing approach which ensures inefficiencies, down 
time and wastage are more fully accounted for, began 
with overall VMMC expenses for 18 districts, extraction 
of expenses for the five RCT districts and then stepwise 
allocation to respective cost centres.51 61 Expenditure data 
included any transactions already incurred before the 
demand creation programme started. Demand creation 
expenses assessed were capital and start- up (development 
costs, initial IPC training, equipment) and recurrent 
costs (personnel, vehicle operation and maintenance, 
communication and education, HIVST kits, promotional 
supplies, training and meetings, consultancy/service fees 
and monitoring and evaluation (M&E)). Online supple-
mental file 2 provides more detailed definitions of the 
cost categories and study cost inputs.
A proportion of the value of office equipment for 
central, regional and district staff plus IPC tablets used 
to record programme M&E data was allocated based on 
staff level of effort dedicated to the programme. Cost 
allocation followed predefined allocation factors, based 
on project M&E data, including the proportion of IPC 
agents trained, proportion of active IPC agents, propor-
tion of clients reached, proportion circumcised, propor-
tion of distributed HIVST kits, proportion of information, 
education and communication material and distance 
from central office.52 56 Online supplemental table A3 
presents allocation factors applied to each input type.
In addition to the analysis of the PSI demand creation 
programme expenditures, we also used the microcosting 
exercise to estimate the costs of VMMC service- delivery at 
the health facility- level. We estimated both direct (consum-
ables and non- consumable commodities, personnel sala-
ries and reimbursement scheme costs as well as training 
costs) and indirect VMMC service costs (capital costs, 
waste management costs, support personnel costs and 
programme supervision costs at the district level). Each 
input required to provide VMMC services was quantified 
(microcosting) and valued. Shared overhead costs such 
as management, building space and equipment were 
allocated to clinic services based on recorded usage. 
Space was used to allocate security, reception, mainte-
nance services and utilities costs.
We estimated total programme costs by adding up the 
costs of demand creation and service- delivery. We then 
proceeded to derive an average cost per client reached and 
circumcised by dividing the full total programme cost by the 
number of clients reached and circumcised. We assessed 
the relationship between unit cost and scale (number of 
Table 2 Overview of VMMC service- delivery models
VMMC service- delivery 
model
Static (fixed) (district 
hospital sites)
Integrated mobile health facility 
sites
Mobile outreach health 
facility sites
Specific characteristics  ► Public sector trained 
clinicians
 ► Public sector trained clinicians  ► Public sector trained 
clinicians




 ► Public sector remuneration 
supplemented by programme 
incentives




 ► VMMC provided at 
district health facilities 
on a continuous basis
 ► Trained clinicians from district 
hospitals deployed to existing 
health facilities intermittently
 ► VMMC offered through 
mobile clinic services 
when recruited numbers 
justified
 ► VMMC offered to walk- in 
clients
 ► VMMC services provided on 
specific days
 ► VMMC offered at more 
remote health facility 
sites
   ► Ongoing facility capacitation to 
eventually assume full VMMC 
site status including training 
of local staff and adequate 
equipment
 ► Temporary operating 
theatres set up for 1 day 
at a time
VMMC, voluntary medical male circumcision.
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clients circumcised) for the three VMMC service- delivery 
models. We also assessed changes in unit costs per client 
circumcised when combining demand creation and 
VMMC service- delivery costs and considering VMMC 
service- delivery characteristics such as type of facility, urba-
nicity, ownership (privately- run (church) vs public- sector 
run clinics) and size of facility in terms of annual number 
of clients served. All costs were analysed in 2018 US$.
Sensitivity analysis
We conducted one- way sensitivity analyses to assess the 
impact of key assumptions on the unit cost per client 
reached and circumcised. We varied the discount rate 
used to annualise costs between 0% and 15% to assess 
impact of zero discounting or using the Zimbabwe central 
bank discount rate (prevailing discount rates during the 
study period was 7%). We further evaluated the impact 
of decreasing or increasing (±10%) costs of training, 
commodities, personnel, other capital costs including 
programme and promotional equipment as well as 
communication and education (mobilisation). To assess 
impact of longer or shorter project duration, we varied 
annualisation (economic life years) time frames: VMMC 
programme start- up life between 3 and 7 years (base case 
is 5 years); training between 1 and 3 years (base case is 4 
years); furniture and equipment between 3 and 7 years 
(base case is 5 years); building economic life between 20 
and 50 years (base case is 35 years); vehicle economic life 
between 5 and 15 years (base case is 10 years).
Patient and public involvement
Patients or members of the public were not involved in 
the design, or conduct, or reporting, or dissemination 
plans of the research.
RESULTS
Total costs and cost composition
Table 3 summarises the findings of the cost analysis. The 
total annual programme cost was $752 585 across the four 
demand creation approaches including service- delivery. 
The average cost per client reached with demand crea-
tion plus cost per circumcision were $58 and $174, 
respectively. Highest costs per client reached were in the 
HCD arm—$68 and lowest costs in standard demand 
creation ($52) and HIVST ($55) arms, respectively. The 
highest cost per client circumcised was observed in the 
arm where HIVST and HCD were combined ($226) and 
the lowest in HCD alone arm ($160).
Figure 1 presents the cost composition across each of the 
demand creation+VMMC service- delivery models. Demand 
creation recurrent costs account for more than half (57%) 
of the programme costs and VMMC service- delivery 
inputs (consumables and non- consumable commodities, 
personnel salaries and reimbursement scheme costs as 
well as training costs) for almost one third (34%). Capital 
and personnel costs represent 9% and 4% of the total cost, 
respectively. Panel B of figure 1 shows the composition 
of VMMC cost by the VMMC delivery model. Personnel 
costs account for 50%, 42% and 36% of total cost for static 
(fixed) model, outreach and integrated mobile model, 
respectively. Capital costs present the lowest relative weight 
across the three types of VMMC delivery. VMMC unit cost 
per circumcision was lowest in the static (fixed) service- 
delivery model ($54) and highest in the integrated service- 
delivery model ($63) (figure 2).
Figure 3 displays the relationship between unit cost 
and scale (number of clients circumcised) for the three 
VMMC service- delivery models. We observed a negative 
relationship between these variables for the three types 
of VMMC delivery consistent with economies of scale. 
In figure 4 (also see online supplemental table A1), we 
show changes in the total unit cost per client circumcised 
when combining demand creation and VMMC service- 
delivery costs by VMMC service- delivery characteristics 
(clinic or hospital, private or public and low or high 
volume). VMMC unit costs (combining demand creation 
and service- delivery) were lowest in rural high- volume 
privately run (church) clinics within the HIVST model 
($86) and highest in rural low- volume public- sector run 
clinics within the standard mobilisation arm ($288). 
Within the SDM arm, unit costs ranged from $153 in 
rural high- volume privately run (church) hospitals to 
about $288 where circumcisions were performed in 
rural- low- volume public- sector run clinics, representing 
the arm with the highest unit cost when comparing all 
four demand creation approaches. The lowest unit costs 
were observed in the HCD+HIVST model ranging from 
$87 in rural high- volume privately- run (church) clinics to 
$141 in rural- low- volume- public sector run clinics.
Sensitivity analysis results
Online supplemental figures A1 and A2 display results 
of the sensitivity analysis for both clients reached and 
circumcised which remained robust when key cost 
parameters were varied. Unit costs were highly sensi-
tive to programme annualisation (economic life years) 
time frames (for training and start- up) and increases or 
decreases in commodities and personnel costs. Varying 
VMMC programme training life between 2 and 6 years 
resulted in costs of $57.17 and $61.32 per client reached 
and $170.95 and $183.35 per client circumcised. Varying 
VMMC programme start- up life between 3 and 7 years 
resulted in costs of $57.76 and $59.26 per client reached 
and $172.71 and $177.19 per client circumcised. Varying 
commodities up and down 10% resulted in costs of $57.60 
and $58.82 per client reached and $172.24 and $175.86 
per client circumcised. Varying personnel up and down 
10% resulted in costs of $57.74 and $58.68 per client 
reached and $172.65 and $175.45 per client circumcised.
DISCUSSION
This, to our knowledge, is one of the first studies to 
estimate economic costs of VMMC demand creation 
approaches incorporating HCD- informed approaches 
and HIVST to motivate men to take up VMMC. We 
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estimated costs of each of the four models combining 
costs of demand creation and VMMC service- delivery. 
Demand creation and communication costs constituted 
66% of programme costs compared with 34% for VMMC 
service- delivery. Vehicle running costs were the highest 
cost contributor (39%) ahead of staff costs (23%), 
communication and education (7%) and other indi-
rect VMMC costs (6%). There was wide variation in unit 
costs across arms with highest costs per client reached 
and circumcised found in the HCD+HIVST arm and the 
lowest costs in the standard demand creation and HCD 
arms. Despite incurring similarly high demand creation 
activity- related costs, arms 1 (SOC) and 3 (HCD) had 
lower unit costs as they had a higher proportion of clients 
reached and circumcised.
For VMMC service- delivery, unit costs were lowest in 
the static (fixed) service- delivery model and highest in 
the integrated mobile service- delivery approach. Results 
show a negative relationship between unit cost and scale, 
findings consistent with the presence of economies of 
scale. Rural high- volume- private (church- run) clinics 
within the HIVST model had lowest unit costs whereas 
rural- low- volume- public- sector run clinics within the 
standard mobilisation arm had highest costs. Rural high- 
volume- privately (church) run clinics had lowest unit 
costs in the HCD+HIVST model.
Costs of this study are consistent with results from other 
VMMC studies in Zimbabwe and elsewhere in Southern 
Africa although differences in strategies and contexts 
may limit comparability. A similar study assessed costs 
of two models of demand creation and VMMC targeting 
school- going adolescents as part of the CAPRISA study 
in rural KwaZulu- Natal in South Africa and found a cost 
of $127.68 per circumcision for 4987 young men circum-
cised although VMMC service- delivery costs accounted 
for 58% of the total cost, compared with 32% for demand 
creation activities.62 An earlier economic evaluation of 
locally tailored demand creation activities (including mass 
media, community mobilisation and targeted service- 
delivery) in increasing uptake of campaign- delivered 
VMMC among men aged 20–34 years in Tanzania found 
costs per VMMC in the intervention arms were $62 in 
Tabora and $130 in Njombe, and in the control arms $70 
and $191, respectively.43
Key strengths of this analysis include the use of 
combined expenditure analysis and facility microcosting, 
a strategy which ensures all relevant costs are captured 
to the greatest extent possible including any investments 
not fully used.43 50–52 Our study also assessed costs of 
VMMC demand creation across three VMMC service- 
delivery modalities and employed an intensive 3- day 
time and motion analysis at each facility to assess staff 
time allocation.59 60 This minimised the need to rely on 
staff interviews, which are often subject to recall bias. 
Recall bias would have possibly led to overestimation or 
underestimation of time spent on VMMC service- delivery 
versus other integrated services. A further strength of 
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creation costs, which have largely been excluded in 
previous economic analyses of VMMC service provision.43
The cost estimates used in this study may be subject to 
a number of limitations. The cost analysis was performed 
in the context of a RCT and in a non- governmental 
organisation implementer setup. The analysis may there-
fore not reflect scale- up within a public sector model. As 
outlined in the methods section, unit cost estimates were 
also borne out of both expenditure analysis and activity- 
based costing. Although these two approaches combined 
can help us achieve the best cost estimates by minimising 
exclusion of cost inputs such as overheads and donated 
goods, inaccuracies may also arise out of the choice of allo-
cation factors used to assign costs. This analysis, however, 
remains important as it helps cover an important gap in 
the literature on VMMC demand creation and service 
provision economic costs. The study also adds to a small 
but growing literature presenting disaggregated costs of 
VMMC demand creation and service- delivery.
In conclusion, there was high variability in unit costs 
across arms and sites. Highest costs per client circum-
cised were observed in the HCD+HIVST arm and within 
an integrated service- delivery setting. Lowest costs per 
client circumcised were seen in the HCD arm followed 
Figure 1 DC+VMMC programme cost and VMMC delivery cost breakdown. VMMC, voluntary medical male circumcision.
Figure 2 VMMC unit cost by type of service- delivery model. 
VMMC, voluntary medical male circumcision.
Figure 3 VMMC unit cost and scale across models 
of service- delivery. VMMC, voluntary medical male 
circumcision.
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by SDC. This cost variation suggests that efficiency gains 
could be made in VMMC service- delivery across various 
platforms. This is evident in the lower costs exhibited 
in rural high- volume public sector clinics compared 
with rural low- volume private (church- run) clinics. The 
negative relationship between unit cost and numbers 
circumcised suggest economies of scale highlighting the 
need for intensified demand creation activities to opti-
mise uptake of VMMC and achieve optimal utilisation 
of inputs. Based on the findings of this study, the SDC 
and HCD arms provide greater scope for efficiency by 
spreading costs on higher numbers of clients reached 
and circumcised. Mobilisation programmes that inten-
sively target higher conversion rates are therefore needed 
in- order to achieve cost efficiencies.
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